Paula Wróblewska-Łuczka

20PUBLICATIONS
29CO-AUTHORS
Molecular targetsChemotherapyCharacterisation of biological macromoleculesCancer therapy (excl. chemotherapy and radiation therapy)Biologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Sep 09, 2026
Interactions of ACEA and WIN 55,212-2 mesylate with temozolomide and cisplatin in neuroblastoma and glioblastoma cell lines: an isobolographic analysis.

|May 14, 2026
Biological activities and therapeutic potential of soy isoflavones: a focus on anticancer activity.

|Aug 14, 2025
Rasagiline Inhibits Human Melanoma Cell Viability and Interacts Synergistically with Mitoxantrone and Antagonistically with Cisplatin-In Vitro Isobolographic Studies.

Danuta Krasowska, Paula Wróblewska-Łuczka, Michał Chojnacki

|Feb 25, 2025
Screening of the Antimelanoma Activity of Monoterpenes-In Vitro Experiments on Four Human Melanoma Lines.

Paula Wróblewska-Łuczka, Laura Kulenty, Katarzyna Załuska-Ogryzek

|Nov 29, 2023
AM1172 (a hydrolysis-resistant endocannabinoid analog that inhibits anandamide cellular uptake) reduces the viability of the various melanoma cells, but it exerts significant cytotoxic effects on healthy cells: an in vitro study based on isobolographic analysis.

Paweł Marzęda, Paula Wróblewska-Łuczka, Magdalena Florek-Łuszczki

|Jul 29, 2023
Anticancer effect of terpenes: focus on malignant melanoma.

Paula Wróblewska-Łuczka, Justyna Cabaj, Julia Bargieł

Pageof 4

Frequent Collaborators

18 joint publications

Jarogniew J Łuszczki

7 joint publications

Agnieszka Góralczyk

6 joint publications

Katarzyna Załuska-Ogryzek

3 joint publications

Magdalena Florek-Łuszczki